Analisa DiFeo is aProfessor in the Department of Pathology and Obstetrics & Gynecology at the University of Michigan Medical School. Currently, she is the Director of the Michigan Ovarian Cancer Science and Innovation Consortium (MOSAIC). She also serves on numerous grant review committees including as a Charter Member of Developmental Therapeutics at National Cancer Institute and a Standing Member on the Mission Boost Panel for the American Cancer Society. Additionally, she was chosen as Crain’s Cleveland Business 40 Under 40 honoree and received The Norma C. and Albert I. Geller Designated Professorship in Ovarian Cancer Research. She has a broad background in cancer genetics and biology, with specific training and expertise in miRNA biology, chemotherapy resistance, tumor initiation, and the development of patient-based models.